e-Drug3D

1699

M LOVASTATIN

INN
LOVASTATIN

cas 75225-51-3

CLASS

CARDIOVASCULAR
HYPOLIPIDEMIC
ANTICHOLESTEREMIC AGENTS
HYDROXYMETHYLGLUTARYL-COA (HMG-COA) REDUCTASE INHIBITORS

ROUTE (list)

PK parameters

Tmax 3 HOUR
VD 56.5 LITER (65 KILOGRAM)
Cl 28 LITER / HOUR (65 KILOGRAM)
PPB 95 PERCENT
t1/2 1.4 HOUR

Target

TARGET 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE

PDB
3HLG (SIMVASTATIN SYNTHASE (LOVD), FROM ASPERGILLUS TERREUS, S5 MUTANT, S76A MUTANT, COMPLEX WITH LOVASTATIN)

Download experimental 3D coordinates of LVA with added hydrogens

3-hydroxy-3-methylglutaryl-coenzyme A reductase UNIPROT P04035 HMGCR

Download SDF file

1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-[(2S)-2-methyl-1-oxobutoxy]-, (betaR,deltaR,1S,2S,6R,8S,8aR)-

Formula:
C24H38O6

Calculated chemical properties:

MW 421.54
NB_atoms 30
XLogP 2.38
PSA 92.85
NB_HD 2
NB_HA 6
fsp3 0.75
Lipinski(0=no;1=yes) 1

FDA
-